BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19647193)

  • 1. Diagnosing patients with hereditary paraganglial tumours.
    Erlic Z; Neumann HP
    Lancet Oncol; 2009 Aug; 10(8):741. PubMed ID: 19647193
    [No Abstract]   [Full Text] [Related]  

  • 2. Late diagnosis of an index case of SDH-related paraganglioma/pheochromocytoma syndrome.
    Sánchez-Pacheco Tardón M; Serrano Corredor S; Carrión A; Mauri M; Yuste A
    Endocrinol Nutr; 2012 Feb; 59(2):148-50. PubMed ID: 22138625
    [No Abstract]   [Full Text] [Related]  

  • 3. Hereditary paraganglioma-pheochromocytoma syndrome.
    Sanchez Cifuentes A; Candel Arenas MF; Albarracín Marín-Blazquez A
    Med Clin (Barc); 2018 Nov; 151(10):e57-e58. PubMed ID: 29656766
    [No Abstract]   [Full Text] [Related]  

  • 4. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
    Rusyn L; Kohn B
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary pheochromocytoma and paraganglioma.
    Mazzaglia PJ
    J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
    Srirangalingam U; Walker L; Khoo B; MacDonald F; Gardner D; Wilkin TJ; Skelly RH; George E; Spooner D; Monson JP; Grossman AB; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):587-96. PubMed ID: 18419787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SDHD-related chromaffin tumours: disease localisation to genetic dysfunction.
    Srirangalingam U; Khoo B; Matson M; Carpenter R; Reznek R; Maher ER; Chew SL; Drake WM
    Horm Res Paediatr; 2010; 73(2):135-9. PubMed ID: 20190551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A founder SDHB mutation in Portuguese paraganglioma patients.
    Martins RG; Nunes JB; Máximo V; Soares P; Peixoto J; Catarino T; Rito T; Soares P; Pereira L; Sobrinho-Simões M; Santos AP; Couto J; Henrique R; Matos-Loureiro J; Dias P; Torres I; Lima J
    Endocr Relat Cancer; 2013 Dec; 20(6):L23-6. PubMed ID: 24092654
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
    Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
    BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
    Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
    Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].
    van der Kleij-Corssmit EP; Havekes B; Vriends AH; Jansen JC; Romijn JA
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):489-93. PubMed ID: 18389879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pheochromocytoma and paraganglioma].
    Gimenez-Roqueplo AP
    Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
    Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
    Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
    Barletta JA; Hornick JL
    Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma?
    Erlic Z; Neumann HP
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetic basis of pheochromocytoma: who to screen and how?
    Plouin PF; Gimenez-Roqueplo AP
    Nat Clin Pract Endocrinol Metab; 2006 Feb; 2(2):60-1. PubMed ID: 16932255
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges in the diagnosis of pheochromocytoma and paraganglioma syndrome.
    Zdrojowy-Wełna A; Bednarek-Tupikowska G
    Neuro Endocrinol Lett; 2014; 35(5):355-8. PubMed ID: 25275255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; from SDHD, a defect in the respiratory chain, to paragangliomas and pheochromocytomas].
    Taschner PE; Bröcker-Vriends AH; van der Mey AG
    Ned Tijdschr Geneeskd; 2002 Nov; 146(46):2188-90. PubMed ID: 12467161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma.
    Hofman MS; Hicks RJ
    Clin Cancer Res; 2015 Sep; 21(17):3815-7. PubMed ID: 26152741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The approach to the patient with paraganglioma.
    Neumann HP; Eng C
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2677-83. PubMed ID: 19657044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.